甘李药业: 关于注销回购股份并减少注册资本暨通知债权人的公告

Group 1 - The company has approved a share repurchase plan to buy back its own A-shares, with a maximum price of RMB 62.76 per share and a total repurchase fund ranging from RMB 150 million to RMB 300 million, to be executed within 12 months [1][2] - The purpose of the repurchased shares has been adjusted from employee stock ownership plans or equity incentives to cancellation and reduction of registered capital [2] - A total of 3,540,021 shares have been repurchased, accounting for 0.5890% of the company's total share capital, with a total expenditure of approximately RMB 150.07 million [2] Group 2 - Following the cancellation of the repurchased shares, the company's total share capital will decrease from 601,065,290 shares to 597,525,269 shares, and registered capital will reduce from RMB 601,065,290 to RMB 597,525,269 [3] - Creditors are notified that they have 30 days from receiving the notice or 45 days from the announcement date to claim their debts or request guarantees [3][4] - Required documents for creditors to declare their claims include contracts, agreements, and other proof of debt, along with identification and authorization documents if applicable [3]